Most men should start discussing prostate cancer screening between ages 45 and 50, with repeat testing every two to four years depending on their results and risk factors. There’s no single schedule that fits everyone. Your age, family history, race, and initial PSA levels all shape how often you need to be checked.
When to Start Screening
The right age to begin depends on your risk profile. The American Urological Association recommends that average-risk men begin screening conversations at age 50. But if you carry higher risk, the timeline moves up significantly:
- Age 50: Average-risk men with no family history
- Age 45: Black men, or men with a father or brother diagnosed with prostate cancer before age 65
- Age 40: Men with more than one first-degree relative diagnosed at an early age, or men who carry a BRCA2 gene mutation
The American Cancer Society uses the same age tiers. Black men face roughly double the risk of dying from prostate cancer compared to white men, which is why earlier screening matters for this group. Men with BRCA1 mutations should also consider starting at 40, though the evidence is strongest for BRCA2 carriers.
How Often to Get Tested
Your first PSA result is the single biggest factor in determining how often you’ll need follow-up tests. PSA (prostate-specific antigen) is a protein measured through a simple blood draw. Higher levels can signal prostate cancer, though they can also rise from non-cancerous conditions like an enlarged prostate or infection.
Here’s how the intervals generally break down:
- PSA below 1 ng/mL: You can safely extend the gap between tests. Some guidelines suggest retesting only every four years or even longer, since your near-term cancer risk is very low.
- PSA between 1 and 2.5 ng/mL: Retesting every two years is reasonable for most men.
- PSA between 2.5 and 3 ng/mL: Annual screening is appropriate. The American Cancer Society recommends yearly testing for anyone above 2.5 ng/mL.
- PSA above 3 ng/mL: Your doctor will likely recommend further evaluation, which could include imaging or a biopsy depending on other factors.
The AUA’s current guideline puts the standard interval at every two to four years for men aged 50 to 69, with room to shorten that window based on individual risk. Men with Black ancestry, strong family history, or known genetic mutations may benefit from screening on the shorter end of that range, around every one to two years.
What the Numbers Mean
There’s no single “normal” PSA number. As a general benchmark, men under 60 should be at or below 2.5 ng/mL, while men 60 and older should be at or below 4.0 ng/mL. But context matters more than any cutoff. A PSA of 3.5 in a 62-year-old might be perfectly fine, while a PSA that doubles quickly over a year or two could be concerning even if the absolute number still looks low.
That’s why tracking your PSA over time is more useful than fixating on a single reading. Your doctor will compare each new result against your previous ones to spot meaningful trends. A slow, steady rise over many years is common with aging. A rapid jump warrants closer attention.
What Screening Actually Involves
The core of modern prostate screening is the PSA blood test. It’s a standard blood draw, nothing more. Results usually come back within a few days.
The digital rectal exam, where a doctor physically checks the prostate through the rectum, used to be a routine part of every screening. Its role has shrunk considerably. Advanced prostate MRI can detect significant cancers with high sensitivity, and the rectal exam adds little when imaging is available. That said, the exam can still be useful as a quick, low-cost check during a regular physical, particularly for men who aren’t getting imaging. If your doctor recommends one, it takes less than a minute.
When to Stop Screening
The U.S. Preventive Services Task Force recommends against prostate cancer screening for men over 70, regardless of race or family history. The reasoning is straightforward: prostate cancer typically grows slowly, and men diagnosed after 70 are more likely to die of something else before the cancer ever causes problems. Treatment side effects, including urinary incontinence and sexual dysfunction, can significantly reduce quality of life without extending it.
There is one exception. For men over 75 who are in excellent health with a life expectancy of at least 10 more years and a PSA below 3 ng/mL, the AUA says continued screening every two to four years is reasonable. But for most men, 70 is a natural stopping point, and for those 75 and older with low PSA levels, screening can be safely discontinued or stretched to much longer intervals.
Why Screening Is a Conversation, Not a Mandate
Every major medical organization frames prostate screening as a shared decision between you and your doctor rather than a blanket recommendation. This isn’t because screening is controversial for the sake of it. The tradeoffs are real. PSA testing catches many cancers that would never cause symptoms or shorten a man’s life. Finding those cancers can lead to biopsies, anxiety, and treatments with lasting side effects for a disease that didn’t need treating.
On the other hand, screening does catch aggressive cancers early, when they’re most treatable. The benefit is clearest for men between 55 and 69, particularly those with risk factors. The key is going into the conversation knowing your family history, understanding that a high PSA doesn’t automatically mean cancer, and being prepared for the possibility that “watch and wait” is sometimes the smartest response to an abnormal result.
If you’re in your mid-40s with any risk factor, or approaching 50 with none, bring it up at your next visit. That first PSA number will set your screening schedule from there.